Vaccine Leaders Make Trial Plans Public in Transparency Push
- Moderna, Pfizer, AstraZeneca seek to build trust in vaccines
- Detailed plans come as public concerns rise over politics
This article is for subscribers only.
Makers of the leading coronavirus vaccine candidates disclosed detailed information about their pivotal late-stage clinical trials and how they plan to gauge their shots’ safety and effectiveness.
The moves by first Moderna Inc., and then later from Pfizer Inc. and its partner BioNTech SE, follow increasing worry that the effort to develop a Covid-19 vaccine is becoming politicized, and that an inoculation could be rushed to market before it is proven safe and effective. AstraZeneca Plc said in an email it would share its plans as well, though it hadn’t as of Thursday evening in the U.S.